• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

What can we learn about influenza infection and vaccination from transcriptomics?

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2019 May 22:1-9. doi: 10.1080/21645515.2019.1608744. [Epub ahead of print]
[h=1]What can we learn about influenza infection and vaccination from transcriptomics?[/h] Rao S[SUP]1[/SUP], Ghosh D[SUP]2[/SUP], Asturias EJ[SUP]3[/SUP], Weinberg A[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Transcriptomics studies the set of RNA transcripts produced by the genome using high-throughput sequencing and bioinformatics. This growing field has revolutionized our understanding of host-pathogen interactions, revealing new insights into the host response to influenza infection and vaccination. Studies using transcriptomics have identified a unique immunosignature for influenza discernable from other bacterial and viral pathogens, key transcriptional factors that discriminate early from late, mild versus severe, and symptomatic versus asymptomatic infection. Recent studies evaluating the host response to influenza vaccines have revealed key differences in live versus inactivated influenza vaccines, identified early transcriptional signatures that predict hemagglutinin antibody production following vaccination, increased our understanding of how adjuvants enhance the immune response to influenza vaccine antigens, and demonstrate biologic variability in the response to vaccination due to host factors. These studies demonstrate the potential for influenza transcriptomics to be applied to clinical care, understanding the mechanisms of infection, and informing vaccine development.


[h=4]KEYWORDS:[/h] Influenza; biosignatures; immune profile; systems biology; transcriptomics; vaccination

PMID: 31116679 DOI: 10.1080/21645515.2019.1608744
 
Back
Top Bottom